Status:
COMPLETED
Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients
Lead Sponsor:
Armando Santoro, MD
Conditions:
Malignant Pleural Mesothelioma
Eligibility:
All Genders
Brief Summary
This is a multicenter retrospective analysis .The aim of the present study is to investigate the molecular predictors of vinorelbine response in tumor samples of a series of MPM patients and evaluate ...
Detailed Description
Vinorelbine has recently become an alternative option for palliation in selected pemetrexed-pretreated patients with malignant pleural mesothelioma (MPM). However, nowadays there are no definitive dat...
Eligibility Criteria
Inclusion
- MPM patients treated with vinorelbine in the ≥ second line setting will be retrospectively analyzed
- Patients will be selected based on the availability of tumor tissue
Exclusion
- NA
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01865045
Start Date
November 1 2012
End Date
December 1 2017
Last Update
September 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinico Humanitas
Rozzano, Milan, Italy, 20089